In a separate study we found that adjunct corticosteroid therapy modifies the inflammatory profile of those who develop TB-IRIS, with lower concentrations of IFN-gamma, IP-10, TNF, IL-6, IL-8, IL-10, IL-12p40, and IL-18 [11]. Here, IL6 is linked to tuberculosis.